Skip to content

Nursing Homes on Constipation and General Comfort

The Effect of Reminiscence Therapy Applied to Elderly Individuals Staying in Nursing Homes on Constipation and General Comfort

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06788392
Enrollment
70
Registered
2025-01-23
Start date
2024-09-01
Completion date
2025-02-01
Last updated
2025-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation, Nursing Caries

Keywords

the elderly, constipation, comfort, reminiscence therapy

Brief summary

The Effect of Reminiscence Therapy on Constipation Applied to Elderly Individuals Staying in a Nursing Home in Giresun Province

Detailed description

Research; This study will be conducted to determine the effect of reminiscence therapy, given once or twice a week to elderly people living in nursing homes, on constipation by reducing stress levels. It is thought that the results obtained will provide evidence for reducing constipation, which significantly limits life. Patients who complain of constipation at the Nursing Home Elderly Care and Rehabilitation Center, who voluntarily agree to participate in the research and who meet the sample selection criteria will be included in the study. Patient information will be collected and the research pre-test, post-test and application will be carried out face to face.

Interventions

Reminiscence Therapy is a supportive care model that has been used in recent years and increases life comfort.

Sponsors

Kafkas University
CollaboratorOTHER
Giresun Huzurevi Yaşlı Bakım ve Rehabilitasyon Merkezi
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Masking description

In the study, blinding will be performed only in the assignment-randomisation to groups and statistical analysis of the results.

Intervention model description

Block randomisation will be used to ensure that the number of patients in each group is balanced. Patients will be divided into two groups, each group consisting of at least 38 people, by a statistician who is not involved in the study, using a table of random numbers.

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for the study: * Those aged 65 and over, * Able to answer all questions and be communicative, * Scoring 24 or above from the Mini Mental test, * Agreeing to participate in the research, * Diagnosed with constipation by the institution physician and meeting the Rome III Constipation Diagnostic Criteria, * There is no deterioration in skin integrity or infection in the abdominal area, * No diarrhea, * Individuals without a history of abdominal surgery will be included in the study.

Exclusion criteria

* Psychiatric drug users, * Those who score below 24 on the Mini Mental Test, * Those who do not meet the Rome III Diagnostic Criteria for Constipation, * Those with impaired skin integrity or infection in the abdominal area, * People with diarrhoea, * History of abdominal surgery Those who refused to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Constipation Severity Scale (CSS) General ComfortConstipation levels will be measured at the begining of the study (pre-test) and end of the intervention of the 5 weeks (post test)It was developed by Varma et al. in 2008. It is a scale for determining the frequency, intensity and difficulty/difficulty during defecation.
Defecation Monitoring Form in a Standard Diary (DMFSD)Constipation status will be monitored at the beginning of the study and daily for 5 weeksIn the form developed by Pamuk et al. (2003) there is a 7-day follow-up schedule consisting of 5 items, including the number of defecation, the amount of stool, the stool consistency, the feeling of buckling during defecation and the feeling of not fully emptying after defecation. For each symptom of constipation, all scores collected during the pre-treatment (7 days), sequence of application (21 days) and post-treatment (7 days) days were calculated by dividing the number of defecations performed within the same days.
General Comfort QuestionnaireComfort levels will be measured at the begining of the study (pre-test) and end of the intervention of the 5 weeks (post test)It was developed by Kolcaba in 1992. A validity and reliability study was conducted by Kuğuoğlu and Karabacak in 2004. The General Comfort Scale is used to determine the comfort needs and to evaluate the state of achieving the result of increasing the expected comfort with the nursing interventions that constitute comfort, which includes three levels (relief, relaxation and superiority) and four dimensions (physical, psychospiritual, sociocultural and environmental) that constitute the theoretical factors of comfort.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026